Optimum Nutrition sold for more than $300 million with $50 million book value and $185 million in revenue.
Endorsements and related activation costs (TV advertising, social media, etc) are good to achieve brand awareness in the first 5 years of a brand. So, Musclepharm is attractive to a buyer that wants to establish themselves long term in the sports nutrition category as a major player to take out Glanbia and Post Holdings.
I find $150 million debt free....meaning $138 million or $11 per share quite realistically.
More than likely Musclepharm won't owe more than $10 million on lawsuit and investigation. The managers may be the ones that will pay, by giving us back stocks, meaning we could get more.